Drug Price Trends for GS IBUPROFEN PM CAPLET

Average Pharmacy Cost for GS IBUPROFEN PM CAPLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
GS IBUPROFEN PM CAPLET	00113-0050-58	0.13127	EACH	2026-07-22
GS IBUPROFEN PM CAPLET	00113-0050-60	0.13127	EACH	2026-07-22
GS IBUPROFEN PM CAPLET	00113-0050-58	0.12930	EACH	2026-06-17
GS IBUPROFEN PM CAPLET	00113-0050-60	0.12930	EACH	2026-06-17
GS IBUPROFEN PM CAPLET	00113-0050-58	0.12716	EACH	2026-05-20

GS IBUPROFEN PM CAPLET: Market Analysis and Price Projections

Last updated: July 27, 2025

The global ibuprofen market is experiencing significant growth, driven by increasing demand for pain relief medications and over-the-counter (OTC) drugs. GS IBUPROFEN PM CAPLET, a popular nighttime pain reliever and sleep aid, is poised to benefit from this expanding market. Let's delve into a comprehensive market analysis and price projections for this product.

Global Ibuprofen Market Overview

The ibuprofen market is witnessing steady growth worldwide. According to recent market research:

The global ibuprofen market size was valued at USD 1.43 billion in 2023 and is estimated to reach USD 1.76 billion by 2032, growing at a CAGR of 2.44% during the forecast period (2024–2032)[1].

This growth is attributed to several factors, including rising urbanization, increasing awareness of chronic diseases, and growing healthcare expenditure.

Key Market Drivers

1. Rising prevalence of chronic pain conditions
2. Growing aging population
3. Increasing consumer awareness about OTC medications
4. Trend towards self-medication for minor ailments

Regional Market Insights

The Asia-Pacific region currently holds the largest share in the global ibuprofen market and is expected to maintain substantial growth. This is primarily due to:

• Cost-efficient pharmaceutical manufacturing in countries like China and India
• Surge in healthcare expenditures
• Significant aging population, particularly in India

GS IBUPROFEN PM CAPLET: Product Analysis

GS IBUPROFEN PM CAPLET is a combination medication containing ibuprofen and diphenhydramine. It's designed to provide pain relief while also aiding sleep.

Product Composition

Each caplet typically contains:

• 200 mg of ibuprofen (pain reliever)
• 38 mg of diphenhydramine citrate (sleep aid)

Target Market

The product caters to adults and children 12 years and older who experience occasional sleeplessness associated with minor aches and pains.

Market Positioning and Competitive Landscape

GS IBUPROFEN PM CAPLET competes in the analgesic combinations drug class, specifically targeting the nighttime pain relief and sleep aid segment. Its main competitors include branded products like Advil PM and store-brand equivalents.

Competitive Advantages

1. Dual-action formula (pain relief + sleep aid)
2. Established efficacy of ibuprofen for pain management
3. Convenience of a single product for multiple symptoms

Market Challenges

1. Intense competition from both branded and generic products
2. Regulatory scrutiny on OTC pain medications
3. Consumer concerns about potential side effects of long-term use

Price Analysis and Projections

The pricing of GS IBUPROFEN PM CAPLET is influenced by various factors, including production costs, market demand, and competitive pricing strategies.

Current Pricing Trends

While specific pricing for GS IBUPROFEN PM CAPLET isn't provided in the search results, we can draw insights from similar products:

The cost for Advil PM (38 mg-200 mg) oral tablet is around $16 for a supply of 20 tablets, depending on the pharmacy you visit[2].

This translates to approximately $0.80 per tablet for a branded product. Generic versions, including GS IBUPROFEN PM CAPLET, are typically priced lower to compete effectively.

Factors Influencing Future Pricing

1. Raw material costs
2. Manufacturing efficiency
3. Supply chain dynamics
4. Regulatory changes
5. Market competition

Price Projections

Given the projected market growth and increasing demand for OTC pain medications, we can anticipate moderate price increases over the next 5-10 years. However, intense competition in the generic drug market may limit significant price hikes.

Estimated annual price growth: 2-3% (subject to market conditions)

Market Growth Opportunities

1. Expanding Distribution Channels

Increasing presence in online pharmacies and e-commerce platforms can boost accessibility and sales. The convenience of online purchasing is becoming increasingly important to consumers.

2. Product Innovation

Developing new formulations or delivery methods could differentiate GS IBUPROFEN PM CAPLET from competitors. For example, fast-acting or extended-release versions might appeal to different consumer segments.

3. Targeting Specific Demographics

Tailoring marketing efforts towards aging populations or individuals with specific pain conditions could capture untapped market segments.

4. Partnerships with Healthcare Providers

Collaborating with healthcare professionals to promote responsible use of OTC pain medications could enhance brand credibility and drive sales.

Market Risks and Challenges

1. Regulatory Scrutiny

Increased focus on the safety of OTC pain medications may lead to stricter regulations, potentially impacting production costs and market access.

2. Generic Competition

The entry of new generic competitors could lead to price pressures and reduced market share.

3. Changing Consumer Preferences

Growing interest in natural and alternative pain relief methods may pose a challenge to traditional OTC medications.

4. Supply Chain Disruptions

Global events, such as pandemics or geopolitical tensions, can impact raw material availability and distribution networks.

Future Market Outlook

The future of the ibuprofen market, including products like GS IBUPROFEN PM CAPLET, appears promising. Market research indicates:

The global ibuprofen market is projected to reach USD 213.6 million by 2033, growing at a CAGR of 7.9% from 2024 to 2033[4].

This growth trajectory suggests a positive outlook for GS IBUPROFEN PM CAPLET, provided it can maintain its competitive position and adapt to changing market dynamics.

Key Growth Drivers

1. Aging global population
2. Increasing prevalence of chronic pain conditions
3. Growing awareness of OTC medications
4. Expansion of e-commerce and online pharmacies

Potential Market Shifts

1. Increased focus on sustainable and environmentally friendly packaging
2. Integration of digital health technologies for medication management
3. Rise of personalized medicine approaches in pain management

Strategies for Market Success

To capitalize on market opportunities and navigate potential challenges, consider the following strategies:

1. Invest in Research and Development

Continuous innovation in formulation and delivery methods can help maintain a competitive edge.

2. Expand Digital Presence

Develop a strong online marketing strategy and ensure easy access through e-commerce platforms.

3. Focus on Consumer Education

Provide clear, accessible information about proper use, benefits, and potential side effects to build trust and promote responsible consumption.

4. Monitor Regulatory Landscape

Stay informed about potential regulatory changes and proactively adapt to ensure compliance.

5. Optimize Supply Chain

Invest in robust supply chain management to mitigate risks of disruption and ensure consistent product availability.

Key Takeaways

• The global ibuprofen market is projected to reach USD 213.6 million by 2033, growing at a CAGR of 7.9%.
• GS IBUPROFEN PM CAPLET benefits from increasing demand for nighttime pain relief and sleep aid products.
• Price projections suggest moderate annual increases of 2-3%, subject to market conditions.
• Key growth opportunities include expanding distribution channels, product innovation, and targeting specific demographics.
• Major challenges include regulatory scrutiny, generic competition, and changing consumer preferences.
• Success strategies involve investing in R&D, expanding digital presence, focusing on consumer education, and optimizing supply chain management.

FAQs

1. Q: How does GS IBUPROFEN PM CAPLET differ from regular ibuprofen? A: GS IBUPROFEN PM CAPLET combines ibuprofen with diphenhydramine, providing both pain relief and sleep aid in one product.

2. Q: What is the projected market size for ibuprofen by 2033? A: The global ibuprofen market is projected to reach USD 213.6 million by 2033.

3. Q: What are the main factors driving growth in the ibuprofen market? A: Key drivers include the aging global population, increasing prevalence of chronic pain conditions, and growing awareness of OTC medications.

4. Q: How might future regulatory changes impact the market for products like GS IBUPROFEN PM CAPLET? A: Increased regulatory scrutiny could lead to stricter production standards or labeling requirements, potentially impacting costs and market access.

5. Q: What strategies can manufacturers employ to stay competitive in the ibuprofen market? A: Key strategies include investing in R&D for product innovation, expanding digital presence, focusing on consumer education, and optimizing supply chain management.

Sources cited: [1] https://straitsresearch.com/report/ibuprofen-market [2] https://www.drugs.com/price-guide/advil-pm [4] https://www.alliedmarketresearch.com/ibuprofen-market-A65446